Research & Innovation
Study shows high-precision radiation therapy is safe for patients with cancer that has spread throughout the body
February 3, 2025 A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision radiation therapy is safe for use in patients with cancer that has spread to more than 10 spots in the body. The
London Health Sciences Centre first in Canada to implant cutting edge cardioverter defibrillator
November 13, 2024 In a Canadian first, London Health Sciences Centre (LHSC) was the first and only hospital in Canada to implant a new extravascular implantable cardioverter defibrillator (ICD) during clinical trials. The global study has led to
Study provides clarity around blood pressure management in non-cardiac surgery
November 4, 2024 Worldwide, more than 300 million non-cardiac surgeries are performed each year. Yet physicians remain unsure about the best way to manage blood pressure during operation to ensure patient safety and prevent damage to organs, like the
Cancer patient first in Canada to be treated with a rare radioisotope
A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with neuroendocrine tumours (NETs) – a rare form of cancer – using a radioisotope (an atom that releases radiation) called actinium-225
Launching LHSCRI: Highlights from our open house events
On October 16, 2024, hundreds of staff members, physicians, partners, community members and government officials joined us to celebrate the launch of London Health Sciences Centre Research Institute (LHSCRI). The day provided a behind-the-scenes look